Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Egypt flag Egypt · Delayed Price · Currency is EGP
156.52
+1.97 (1.27%)
At close: Apr 2, 2026
Market Cap3.56B +163.5%
Revenue (ttm)1.52B +23.5%
Net Income387.20M +2.8%
EPSn/a
Shares Out22.75M
PE Ratio9.20
Forward PEn/a
Dividend13.19 (8.43%)
Ex-Dividend DateOct 27, 2025
Volume350,886
Average Volume372,776
Open154.55
Previous Close154.55
Day's Range153.00 - 159.90
52-Week Range67.02 - 232.95
Beta-0.03
RSI53.22
Earnings DateMay 25, 2026

About EGX:MPCI

Memphis Pharmaceuticals & Chemical Industries engages in the research, development, manufacture, marketing, and distribution of pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, central nervous system, dermatological, cardiovascular diseases, vitamins and minerals, analgesics and antipyretics, respiratory system, and gastrointestinal and metabolic disorders. It also provides products for anthelmintic, anti-hypertensi... [Read more]

Industry Pharmaceutical Preparations
Founded 1940
Employees 144
Stock Exchange Egyptian Stock Exchange
Ticker Symbol MPCI
Full Company Profile

Financial Performance

In fiscal year 2025, EGX:MPCI's revenue was 1.51 billion, an increase of 72.93% compared to the previous year's 871.91 million. Earnings were 505.28 million, an increase of 163.91%.

Financial Statements